Neuroimmunology is a field that combines neurology (the study of the neurological system) and immunology (the study of the immune system) into one discipline. Neuroimmunologists study the interplay between these two complex systems throughout development, homeostasis, and injury response. One of the long-term goals of this rapidly growing research area is to improve our understanding of the pathology of some neurological diseases, some of which have no known cause. As a result, neuroimmunology aids in the development of new pharmacological treatments for a variety of neurological disorders. The neurological and immunological systems interact in a variety of ways, including physiological functioning in health and sickness, dysfunction of one or both systems that leads to diseases, and physical, chemical, and environmental stresses that influence both systems on a daily basis.
An inflammatory response within the brain or spinal cord is known as neuroinflammation. The generation of cytokines, chemokines, reactive oxygen species, and secondary messengers all play a role in inflammation. Resident CNS glia (microglia and astrocytes), endothelial cells, and peripherally derived immune cells all produce these mediators. These neuroinflammatory responses have immunological, physiological, biochemical, and psychological repercussions.
Title : Diagnosis and differentiation of lyme disease and tick-borne relapsing fever borreliosis with multiplex line immunoblots
Ranjan Ramasamy, IDFISH Technology, United States
Title : Mast cell degranulation links anti-PEG IgE to anaphylaxis caused by PEGylated drugs and PEG-contained LNP/mRNA COVID vaccines
Zhaohua Zhou, Food and Drug Administration, United States
Title : Genetic factors influencing early immunity to SARS-CoV-2 in the upper respiratory tract
Ranjan Ramasamy, IDFISH Technology, United States
Title : Monoclonal antibodies efficacy in treatment of novel coronavirus infection (COVID-19) in children at risk of developing a severe course of the disease
Ismail Osmanov, Children's city clinical hospital, Russian Federation
Title : Considerations on MS animal modeling: Format of myelin immunogens used for experimental autoimmune encephalomyelitis model establishment may affect pharmacologic responses of anti-inflammatory drugs
WenQing Yang, Founder/Chief Scientific Officer, ClinBridge Biotech Corp., China
Title : Regulatory T cells with chimeric antigen receptors as treatment for autoimmunity
Matthias Hardtke Wolenski, Hannover Medical School, Germany